Randomized Phase II Evaluating EGFR-TKI Associated with Anti-Estrogen in Women with Non-Squamous Advanced Stage NSCLC: IFCT-1003 LADIE Trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreRandomized Phase II Evaluating EGFR-TKI Associated with Anti-Estrogen in Women with Non-Squamous Advanced Stage NSCLC: IFCT-1003 LADIE Trial
Type de publicationJournal Article
Year of Publication2018
AuteursMazieres J., Barlesi F., Rouquette I., Besse B., Monnet I., Audigier-Valette C., Toffart A., Renault A., Moreau S., Hiret S., Mennecier B., Debieuvre D., Westeel V., Masson P., Madroszyk A., Amour E., Morin F., Zalcman G., Moro-Sibilot D., Souquet P.J
JournalJOURNAL OF THORACIC ONCOLOGY
Volume13
PaginationS487
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN1556-0864
Mots-clésEGFR-TKI, fulvestrant, NSCLC
DOI10.1016/j.jtho.2018.08.622